Home
Live Updates
Strides receives USFDA approval for Sucralfate oral suspension; stocks move up : vimarsana.com
Strides receives USFDA approval for Sucralfate oral suspension; stocks move up
Strides Pharma gains 0.76% as USFDA approves Sucralfate Oral Suspension, expanding product portfolio and market reach.
Related Keywords
Singapore ,
Bengaluru ,
Karnataka ,
India ,
,
Strides Pharma Science Ltd ,
Linkedin ,
Facebook ,
Strides Pharma Global Pte Ltd ,
United States Food Drug Administration ,
Twitter ,
United States Food ,
Drug Administration ,
Sucralfate Oral Suspension ,
Oral Suspension ,
Reference Listed Drug ,
Chestnut Ridge ,
vimarsana.com © 2020. All Rights Reserved.